14.43
Schlusskurs vom Vortag:
$14.77
Offen:
$14.4
24-Stunden-Volumen:
260.65K
Relative Volume:
0.55
Marktkapitalisierung:
$625.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+9.61%
1M Leistung:
-8.21%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BBNX
Beta Bionics Inc
|
14.43 | 648.61M | 0 | 0 | 0 | 0.00 |
![]()
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-16 | Eingeleitet | Truist | Buy |
2025-06-12 | Eingeleitet | Lake Street | Buy |
2025-05-30 | Eingeleitet | Goldman | Neutral |
2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
2025-02-24 | Eingeleitet | BofA Securities | Buy |
2025-02-24 | Eingeleitet | Lake Street | Buy |
2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
2025-02-24 | Eingeleitet | Stifel | Buy |
2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
What drives Beta Bionics Inc. stock priceUnstoppable profit momentum - Autocar Professional
Is Beta Bionics Inc. a good long term investmentStrongest growth potential - Autocar Professional
What analysts say about Beta Bionics Inc. stockRobust financial gains - Autocar Professional
Beta Bionics Inc. Stock Analysis and ForecastTriple-digit return opportunities - Autocar Professional
Beta Bionics, Inc.’s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX) - Defense World
Is Sprinklr Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
NIP Group Inc. Depositary Receipt Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional
Investing in IT Sector Top Investment Strategy ToolsExplosive trading opportunities - jammulinksnews.com
SKF India Limited (SKFINDIA) Stock RalliesFree Trend-Following Techniques - jammulinksnews.com
Best Indian Stocks for Stable Returns Professional Trading PicksFree Predictions - jammulinksnews.com
Beta Bionics (BBNX) Drops 2.15% Despite Abbott Partnership - AInvest
Why Beta Bionics Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
How Beta Bionics Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
What makes Beta Bionics Inc. stock price move sharplyLow Risk Scalping Alerts - Newser
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns - Benzinga
Beta Bionics, Inc. to Release Q2 2025 Financial Results on July 29, 2025 - Nasdaq
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
Tracking Blood Sugar: A Multi-Billion Dollar Industry's Remarkable Journey - Medical Device and Diagnostic industry
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors - MedTech Dive
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - Zacks Investment Research
Analysts expect Beta Bionics patch pump launch by 2027 - MassDevice
5 things to watch at the ADA’s Scientific Sessions - MedTech Dive
Beta Bionics, Inc. Announces Integration of iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor - Nasdaq
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight - GlobeNewswire Inc.
Beta Bionics (NASDAQ:BBNX) Now Covered by Truist Financial - Defense World
Beta Bionics initiated with a Buy at Truist - TipRanks
Beta Bionics, Inc.: Strategic Growth and Market Penetration with iLet Infusion Pump - TipRanks
Beta Bionics stock initiated with Buy rating at Truist Securities By Investing.com - Investing.com South Africa
Beta Bionics stock initiated with Buy rating at Truist Securities - Investing.com
Lake Street Capital Initiates Coverage on Beta Bionics (NASDAQ:BBNX) - Defense World
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Es liegen keine Finanzdaten für Beta Bionics Inc (BBNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):